CDC authorizes COVID-19 vaccines for children 5-11 years of age
Author
![Blaire-Bryant.jpg Image of Blaire-Bryant.jpg](https://www.naco.org/sites/default/files/styles/610x610/public/Blaire-Bryant.jpg?h=b62b62f2&itok=esAZs_3f)
Blaire Bryant
Upcoming Events
Related News
![GettyImages-1315887649.jpg Image of GettyImages-1315887649.jpg](https://www.naco.org/sites/default/files/styles/807x448/public/GettyImages-1315887649.jpg?h=eb65c5a4&itok=Cm-m93Wi)
Key Takeaways
On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.
The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.
On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.
As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.
ADDITIONAL RESOURCES
Resource
COVID-19 Vaccine Toolkit for Counties
![GettyImages-1205972800.jpg Image of GettyImages-1205972800.jpg](https://www.naco.org/sites/default/files/styles/667x579/public/articles/GettyImages-1205972800_0.jpg?h=0483d7ba&itok=fcOE2bCw)
Related News
![SAMHSA is prioritizing peer-centered recovery, among other ways to combat youth substance use disorder, Sonia Chessen, SAMHSA’s deputy assistant secretary, said Friday, July 12 at the NACo Health Steering Committee meeting. Photo by Leon Lawrence III](https://www.naco.org/sites/default/files/styles/385x285/public/2024-07/Sonia%20Chessen%20LL3.jpeg?h=dcdd4b03&itok=b009ZbxV)
Collaboration and mental health support address youth substance use disorder
Counties are investing in education, harm reduction and peer support recovery to combat unintentional overdoses.
![Doctor on tablet](https://www.naco.org/sites/default/files/styles/385x285/public/2024-06/GettyImages-1492368685.jpg?h=80e376df&itok=LmsuWQgH)
Ten states added to the Certified Community Behavioral Health Clinics Medicaid Demonstration Program
On June 4, the U.S. Department of Health and Human Services, through CMS and SAMHSA, announced that ten new states have joined the Certified Community Behavioral Health Clinic Medicaid Demonstration Program.
![THE_County Countdown_working_image-4.png](https://www.naco.org/sites/default/files/styles/385x285/public/2023-10/THE_County%20Countdown_working_image-4.png?h=abdb0f6f&itok=66AjrCqr)
County Countdown – June 17, 2024
Every other week, NACo’s County Countdown reviews top federal policy advocacy items with an eye towards counties and the intergovernmental partnership.